Search Within

Richard D Carvajal

Formats
  1. Journal Article (86)
  2. Meeting Abstract (61)
  3. Book Section (1)
Groups
  1. Department of Medicine (100)
  2. Solid Tumor Oncology Division (98)
  3. Melanoma and Immunotherapeutics Service (57)
  4. GSK Faculty (50)
  5. Biostatistics Service (45)
  6. Epidemiology and Biostatistics (45)

More Groups

People
  1. Gary Schwartz (61)
  2. Jedd Wolchok (41)
  3. Paul Chapman (33)
  4. Mark Dickson (29)
  5. Katherine Panageas (22)
  6. Sandra D'Angelo (20)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (4)
  5. 2017 (1)
  6. 2016 (4)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (13)
  3. Annals of Oncology (4)
  4. Cancer (4)
  5. Pigment Cell & Melanoma Research (4)
  6. Annals of Surgical Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (58)
  2. American Association for Cancer Research (18)
  3. Elsevier Inc. (10)
  4. Wiley Blackwell (10)
  5. Springer (9)
  6. Lippincott Williams & Wilkins (7)

More Publishers

Results (148)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma
    Meeting Abstract

    Shoushtari, A. N.; Kudchadkar, R. R.; Panageas, K.; Murthy, R. K.; Jung, M.; Shah, R.; O'Donnell, B.; Khawaja, T. T.; Shames, Y.; Prempeh-Keteku, N. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract
    Journal Article

    Schiavone, M. B.; Broach, V.; Shoushtari, A. N.; Carvajal, R. D.; Alektiar, K.; Kollmeier, M. A.; Abu-Rustum, N. R.; Leitao, M. M. Jr
    Gynecologic Oncology Reports (2016)

    Fulltext@MSK | Save
  • Reply to A. Indini et al.
    Journal Article

    Horvat, T. Z.; Adel, N. G.; Dang, T. O.; Momtaz, P.; Postow, M. A.; Callahan, M. K.; Carvajal, R. D.; Dickson, M. A.; D'Angelo, S. P.; Woo, K. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Survival, durable response, and long-term safety in patients with previously treated advanced renal cell carcinoma receiving nivolumab
    Journal Article

    McDermott, D. F.; Drake, C. G.; Sznol, M.; Choueiri, T. K.; Powderly, J. D.; Smith, D. C.; Brahmer, J. R.; Carvajal, R. D.; Hammers, H. J.; Puzanov, I.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at Memorial Sloan Kettering Cancer Center
    Journal Article

    Horvat, T. Z.; Adel, N. G.; Dang, T. O.; Momtaz, P.; Postow, M. A.; Callahan, M. K.; Carvajal, R. D.; Dickson, M. A.; D'Angelo, S. P.; Woo, K. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of nilotinib in melanoma harboring KIT alterations following progression to prior KIT inhibition
    Journal Article

    Carvajal, R. D.; Lawrence, D. P.; Weber, J. S.; Gajewski, T. F.; Gonzalez, R.; Lutzky, J.; O'Day, S. J.; Hamid, O.; Wolchok, J. D.; Chapman, P. B.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Dose escalation stage of a first-in-class phase I study of the novel oral ERK 1/2 kinase inhibitor BVD-523 (ulixertinib) in patients with advanced solid tumors
    Meeting Abstract

    Infante, J. R.; Janku, F.; Tolcher, A. W.; Patel, M. R.; Sullivan, R. J.; Flaherty, K.; Carvajal, R. D.; Varghese, A. M.; Wong, D. J. L.; Sznol, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials
    Journal Article

    Hyman, D. M.; Eaton, A. A.; Gounder, M. M.; Pamer, E. G.; Pettiford, J.; Carvajal, R. D.; Percy Ivy, S.; Iasonos, A.; Spriggs, D. R.
    Oncotarget (2015)

    Fulltext@MSK | Save
  • A retrospective evaluation of vemurafenib as treatment for BRAF-mutant melanoma brain metastases
    Journal Article

    Harding, J. J.; Catalanotti, F.; Munhoz, R. R.; Cheng, D. T.; Yaqubie, A.; Kelly, N.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Lacouture, M. E.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Overall survival and long-term safety of nivolumab (anti-programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non-small-cell lung cancer
    Journal Article

    Gettinger, S. N.; Horn, L.; Gandhi, L.; Spigel, D. R.; Antonia, S. J.; Rizvi, N. A.; Powderly, J. D.; Heist, R. S.; Carvajal, R. D.; Jackman, D. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save